Ethnic differences in propofol and fentanyl response: a comparison among Caucasians, Kenyan Africans and Brazilians

Background and objective: Differences in sensitivity to anaesthetic drugs may exist among human races. Allelic variants for drug metabolizing isoenzymes and other pharmacokinetic/pharmacodynamic differences may account for a variable response to anaesthetic drugs. This study was designed to investigate comparatively the anaesthetic requirements and the recovery trends of three different ethnic groups: Caucasians, African blacks and Brazilians. Methods: The anaesthetic depth and recovery of groups of 45 patients undergoing total intravenous anaesthesia with propofol and fentanyl were compared. The bispectral index and clinical parameters were used to assess the depth of anaesthesia. The bispectral index, the response to verbal stimuli and the eye opening time were used to assess recovery. Results: After stopping propofol, the bispectral index values of Caucasians returned to the baseline in about 10.8 ± 4 min, that of Kenyan African blacks in 18 ± 7 min and that of Brazilians in a highly variable time ranging from 5 to 25 min, (14.9 ± 9.9). The time from discontinuation of propofol and fentanyl infusion to eye opening was 18.8 ± 7.1 min in African blacks (P < 0.01) and 13.5 ± 8.8 min in Brazilians (P > 0.05) vs. 11.6 ± 4.5 min in Caucasians. Time to respond to verbal commands was 16.8 ± 8 min in African blacks (P < 0.01) and 12.8 ± 8.1 min in Brazilians (P > 0.05) vs. 9.9 ± 4.5 min in Caucasians. Conclusions: The recovery of Kenyan African blacks from anaesthesia with propofol and fentanyl is much slower, in comparison with Caucasians. The recovery time of Brazilians is much more variable, in comparison with Caucasians.

[1]  Bradford Ld.  CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. , 2002 .

[2]  R. Cacabelos,et al.  Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population. , 2000, Methods and findings in experimental and clinical pharmacology.

[3]  E. Azevêdo.  Subgroup studies of black admixture within a mixed population of Bahia, Brazil , 1980, Annals of human genetics.

[4]  C. Fortuna,et al.  Spread and diversity of human populations in Bahia, Brazil. , 1982, Human biology.

[5]  B. Burchell,et al.  The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs. , 1993, Biochemical pharmacology.

[6]  D. Greenblatt,et al.  Cytochrome P-450 2B6 Is Responsible for Interindividual Variability of Propofol Hydroxylation by Human Liver Microsomes , 2001, Anesthesiology.

[7]  E. J. Douglas,et al.  Species differences in blood profiles, metabolism and excretion of 14C-propofol after intravenous dosing to rat, dog and rabbit. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.

[8]  M. Ingelman-Sundberg,et al.  Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity. , 2001, Pharmacogenetics.

[9]  R. Kim,et al.  Molecular basis of ethnic differences in drug disposition and response. , 2001, Annual review of pharmacology and toxicology.

[10]  O. Ortolani,et al.  The Recovery of Senegalese African Blacks from Intravenous Anesthesia with Propofol and Remifentanil Is Slower Than That of Caucasians , 2001, Anesthesia and analgesia.

[11]  R. Boulieu,et al.  Propofol metabolites in man following propofol induction and maintenance. , 2002, British journal of anaesthesia.

[12]  I. Rampil.  A Primer for EEG Signal Processing in Anesthesia , 1998, Anesthesiology.

[13]  J. Vuyk.  Clinical interpretation of pharmacokinetic and pharmacodynamic propofol-opioid interactions. , 2001, Acta anaesthesiologica Belgica.